CNTX stock

News

0 analysts rank CNTX stock as an Overweight

Roman Campbell

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Context Therapeutics ...

Stock Earnings

Examining the Potential Price Growth of Context Therapeutics Inc (CNTX)

Daniel Torres

Context Therapeutics Inc’s filing revealed that its Chief Executive Officer Lehr Martin A. acquired Company’s shares for reported $70080.0 on ...

Knox Daily
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.